Austrija - engleski - HMA (Heads of Medicines Agencies)

boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide

Njemačka - engleski - HMA (Heads of Medicines Agencies)

boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide

Francuska - engleski - HMA (Heads of Medicines Agencies)

boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide

Irska - engleski - HMA (Heads of Medicines Agencies)

boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide

Italija - engleski - HMA (Heads of Medicines Agencies)

boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide

Nizozemska - engleski - HMA (Heads of Medicines Agencies)

boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide

Izrael - engleski - Ministry of Health

teva israel ltd - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

Izrael - engleski - Ministry of Health

teva pharmaceutical industries ltd, israel - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

Izrael - engleski - Ministry of Health

teva pharmaceutical industries ltd, israel - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

Izrael - engleski - Ministry of Health

novartis israel ltd - entacapone - film coated tablets - entacapone 200 mg - entacapone - entacapone - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson`s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.